Mkjd, Llc | |
2040 Fitzhugh St, Batesville, AR 72501-7409 | |
(870) 793-3500 | |
(870) 793-3501 |
Full Name | Mkjd, Llc |
---|---|
Type | Facility |
Speciality | Clinic/center - Rehabilitation |
Location | 2040 Fitzhugh St, Batesville, Arkansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1063986123 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Mkjd, Llc 2040 Fitzhugh St, Batesville, AR 72501-7409 Ph: (870) 793-3500 | Mkjd, Llc 2040 Fitzhugh St, Batesville, AR 72501-7409 Ph: (870) 793-3500 |
News Archive
Cardiome Pharma Corp. today announced that its co-development partner, Astellas Pharma US., Inc., has suspended patient enrollment in the ACT 5 study of KYNAPIDTM (vernakalant hydrochloride) Injection following a single unexpected serious adverse event of cardiogenic shock experienced by a patient with atrial fibrillation who received KYNAPID.
Positron Corporation today announced that the Ministry of Health and Long Term Care of Ontario, Canada is making positron emission tomography (PET) scanning a publicly insured health service available to cancer and cardiac patients under conditions where PET scans have been proven to be clinically effective.
An undergraduate student's technique for detecting certain metabolites in urine samples could lead to a simpler and more accurate way to test for prostate cancer.
Now, in new research, the everyday painkiller aspirin will be evaluated as a potential treatment for COVID-19 in one of the United Kingdom's most significant trials, aiming to evaluate whether it can reduce the risk of blood clots in infected people.
› Verified 6 days ago